Schroder Investment Management Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
33,207
+2,801
| +9% | +$848K | 0.01% | 636 |
|
|
2025
Q1 | $9.97M | Buy |
30,406
+19,359
| +175% | +$6.35M | 0.01% | 642 |
|
|
2024
Q4 | $3.44M | Sell |
11,047
-9,795
| -47% | -$3.05M | ﹤0.01% | 843 |
|
|
2024
Q3 | $4.43M | Buy |
20,842
+8,134
| +64% | +$1.73M | ﹤0.01% | 804 |
|
|
2024
Q2 | $3.56M | Sell |
12,708
-10,993
| -46% | -$3.08M | ﹤0.01% | 840 |
|
|
2024
Q1 | $6.33M | Buy |
23,701
+5,401
| +30% | +$1.44M | 0.01% | 739 |
|
|
2023
Q4 | $4.23M | Buy |
+18,300
| New | +$4.23M | 0.01% | 798 |
|
|
2020
Q1 | – | Sell |
-981
| Closed | -$89K | – | 1358 |
|
|
2019
Q4 | $89K | Buy |
+981
| New | +$89K | ﹤0.01% | 1212 |
|